The global FemTech market is expected to exceed $108bn by 2032, driven by the increasing development of products and services tailored to meet the unique healthcare needs of women.
Women face myriad health requirements distinct from those experienced by men, prompting the evolution of the FemTech sector to address issues such as menstruation, menopause and reproductive health. This is largely due to the underrepresentation of women in medical research. Until 1993, women were routinely excluded from clinical trials, and even today, around 80% of healthcare venture capitalists have not invested in women’s healthcare products. Consequently, significant gaps exist in our understanding of how certain treatments and interventions may impact women differently from men. FemTech has emerged as a response to address some of these critical gaps.
“Putting a face and narrative at the heart of a FemTech brand humanises the service or product.”
Olivia Dias BagottFemTech is a burgeoning sector and these are exciting times. Many products and services are born out of founders’ personal experiences or frustrations with existing healthcare options, which can create a strong emotional connection with potential users facing similar challenges. It’s all about using the right tools to build trust, foster a sense of belonging and combat feelings of isolation. Sharing your story digitally means staying connected to a community and influencing how healthcare services cater to women’s needs.
